SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-000607
Filing Date
2021-01-08
Accepted
2021-01-08 16:30:09
Documents
18
Period of Report
2021-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 37121
2 ex99-1.htm EX-99.1 14693
3 ex99-1_001.jpg GRAPHIC 94749
4 ex99-1_002.jpg GRAPHIC 260176
5 ex99-1_003.jpg GRAPHIC 100071
6 ex99-1_004.jpg GRAPHIC 117558
7 ex99-1_005.jpg GRAPHIC 128937
8 ex99-1_006.jpg GRAPHIC 81746
9 ex99-1_007.jpg GRAPHIC 115933
10 ex99-1_008.jpg GRAPHIC 153993
11 ex99-1_009.jpg GRAPHIC 144207
12 ex99-1_010.jpg GRAPHIC 120123
13 ex99-1_011.jpg GRAPHIC 106037
14 ex99-1_012.jpg GRAPHIC 119878
15 ex99-1_013.jpg GRAPHIC 217664
16 ex99-1_014.jpg GRAPHIC 114254
17 ex99-1_015.jpg GRAPHIC 80991
18 ex99-2.htm EX-99.2 43402
  Complete submission text file 0001493152-21-000607.txt   2791938
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 21517775
SIC: 8071 Services-Medical Laboratories